Arxis, Inc.
For the period ended Sep 30, 2026. Filed Oct 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 29, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
On August 10, 2026, Kevin Perhamus, President, Chief Executive Officer and Director, entered into a 10b5-1 sales plan(the “Perhamus 10b5-1 Sales Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act and providing for the potential exercise of vested stock options and the associated sale of up to 185,000 shares of the Company’s Class A common stock. The Perhamus 10b5-1 Sales Plan will remain in effect until theearlierof (1)May 4, 2027, (2) the date on which all trades set forth in the Perhamus 10b5-1 Sales Plan have been executed, or (3) such time as the Perhamus 10b5-1 Sales Plan is otherwise terminated according to its terms.
On August 12, 2026, Ross Sealfon, President of the Mechanical Components Segment of the Company, entered into a 10b5-1 sales plan (the “Sealfon 10b5-1 Sales Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act and providing for the potential exercise of vested stock options and the associated sale of up to 180,000 shares of the Company’s Class A common stock. The Sealfon 10b5-1 Sales Plan will remain in effect until theearlierof (1)May 18, 2027, (2) the date on which all trades set forth in the Sealfon 10b5-1 Sales Plan have been executed, or (3) such time as the Sealfon 10b5-1 Sales Plan is otherwise terminated according to its terms.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.